Respiratory Medicine

Article	Citations
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)	279
Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae	230
Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China	193
Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians	188
Goals of COPD treatment: Focus on symptoms and exacerbations	141
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?	140
Pulmonary function and health-related quality of life after COVID-19 pneumonia	123
A study on infectivity of asymptomatic SARS-CoV-2 carriers	110
Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis	96
Levels of resilience, anxiety and depression in nurses working in respiratory clinical areas during the COVID pandemic	90
Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae	80
Smoking and COVID-19: What we know so far	79
Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19	76
D-dimer in patients infected with COVID-19 and suspected pulmonary embolism	69
The role of oral microbiome in respiratory health and diseases	69
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudin	64
COVID-19: Why does disease severity vary among individuals?	58
Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic	57
Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge	56
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry	53
Sex differences between women and men with COPD: A new analysis of the 3CIA study	51
Predictors of mortality in fibrosing pulmonary sarcoidosis	50
Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomis	47
Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19	46
Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience	45

Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study	45
Candida spp. co-infection in COVID-19 patients with severe pneumonia: Prevalence study and associated risk factors	44
Idiopathic pulmonary hemosiderosis: A state of the art review	44
Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study	43
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state	43
Evaluation and management of pulmonary arterial hypertension	43
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity	41
“Current place of impulse oscillometry in the assessment of pulmonary diseases.”	41
Follow-up of functional exercise capacity in patients with COVID-19: It is improved by telerehabilitation	40
Risk factors and associated outcomes of hospital readmission in COPD: A systematic review	39
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study	39
Managing malnutrition in COPD: A review	38
Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis	37
Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy	37
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey	37
Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis	37
Tobacco use as a well-recognized cause of severe COVID-19 manifestations	37
Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options	35
Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection	34
Guidance on nebulization during the current COVID-19 pandemic	34
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study	33
Non-CF bronchiectasis: Orphan disease no longer	32
Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan	32
COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity	32
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure	31
Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19	31
Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients	31
Smoking and risk of COVID-19 hospitalization	31
Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS	30
Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications	30
The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature	30
Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge	30
Use of corticosteroids in asthma and COPD patients with or without COVID-19	29
Moving towards a Treatable Traits model of care for the management of obstructive airways diseases	29
Controversy surrounding the Sputnik V vaccine	29
Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study	28
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis	28
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients	28
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea	28
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype	28
The association of anxiety and depression with mortality in a COPD cohort. The HUNT study, Norway	27
Sarcoidosis: A nationwide registry-based study of incidence, prevalence and diagnostic work-up	27
ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2	26
Volatile organic compounds associated with diagnosis and disease characteristics in asthma – A systematic review	26
The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study	25
Aspiration pneumonia: A renewed perspective and practical approach	25
Severity does not impact on exercise capacity in COVID-19 survivors	25
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials	24
Asthma patients' and physicians’ perspectives on the burden and management of asthma	23
Intestinal permeability marker zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease	23

COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale	23
A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia	23
Survival in COPD patients treated with bronchoscopic lung volume reduction	23
Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis	22
Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation	22
Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic	22
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry	22
Electrical impedance tomography: A compass for the safe route to optimal PEEP	22
A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma	22
The use of cough peak flow in the assessment of respiratory function in clinical practice- A narrative literature review	22
Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function	22
The lived experience with pulmonary embolism: A qualitative study using focus groups	22
Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: Real-life data from a Belgian University Hospital	22
Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases	21
Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography	21
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity	21
Chest X-ray features of SARS-CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals	21
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review	21
Platelets in chronic obstructive pulmonary disease: An update on pathophysiology and implications for antiplatelet therapy	20
Large underreporting of COPD as cause of death-results from a population-based cohort study	20
High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients	20
Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study	20
Decreased quality of life and spirometric alterations even after mild-moderate COVID-19	19
Effects of surgical and cloth facemasks during a submaximal exercise test in healthy adults	19
Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study	19
Behavioural modification interventions alongside pulmonary rehabilitation improve COPD patients’ experiences of physical activity	19
Prevalence and features of IOS-defined small airway disease across asthma severities	19
Ultra-low dose rituximab as add-on therapy in anti-MDA5-positive patients with polymyositis /dermatomyositis associated ILD	19
Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis	19
Comparability of asthma control test scores between self and physician-administered test	18
Usefulness of the HACOR score in predicting success of CPAP in COVID-19-related hypoxemia	18
Diagnosis of tuberculous pleural effusions: A review	18
Current perspectives on the immunopathogenesis of sarcoidosis	18
COPD phenotypes and machine learning cluster analysis: A systematic review and future research agenda	18
Predictors of failure of high flow nasal cannula failure in acute hypoxemic respiratory failure due to COVID-19	18
The emerging role of oxidative stress in complications of COVID-19 and potential therapeutic approach to diminish oxidative stress	17
Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies	17
Compliance in subcutaneous and sublingual allergen immunotherapy: A nationwide study	17
Association between chest CT features and clinical course of Coronavirus Disease 2019	17
Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients	17
Update on the diagnosis and management of malignant pleural effusions	17
Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: A multicenter retrospective research network study	17
Endothelial function provides early prognostic information in patients with COVID-19: A cohort study	17
Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: A scoping review	17
Respiratory care for the critical patients with 2019 novel coronavirus	17
12-months follow-up of pulmonary tele-rehabilitation versus standard pulmonary rehabilitation: A multicentre randomised clinical trial in patients with severe COPD	17
Diagnosis and quantification of bronchiectasis using computed tomography or magnetic resonance imaging: A systematic review	17
Chronic rhinosinusitis in COPD: A prevalent but unrecognized comorbidity impacting health related quality of life	16
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort	16
Diagnostic utility of endobronchial ultrasound (EBUS) features in differentiating malignant and benign lymph nodes - A systematic review and meta-analysis	16
Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance	16
Falls prevalence and risk factors in people with chronic obstructive pulmonary disease: A systematic review	16
Mortality and readmission in the year following hospitalization for pneumonia among US adults	16
Factors associated with anxiety and depression among patients with Covid-19	16
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study	16
Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: Implementation of the Mental Health Guidelines	16
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy	16
Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome	15
The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis	15
Paediatric long term continuous positive airway pressure and noninvasive ventilation in France: A cross-sectional study	15
Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study	15
Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD	15
Clinical and biological factors associated with irreversible airway obstruction in adult asthma	15
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry	15
COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort	15
The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis	15
Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis	15
Depressive and anxiety symptoms in patients with COPD: A network analysis	14
Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study	14
Chronic cough in Vocal Cord Dysfunction: Description of a clinical entity	14
The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK	14
Pleuroparenchymal fibroelastosis: Clinical, radiological and histopathological features	14
Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases	14
Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study	14
Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease	14
Pectoralis muscle area and its association with indices of disease severity in interstitial lung disease	14
COPD is a risk factor for COVID-19, but does not confer increased severity of the disease	14
Safe extubation during the COVID-19 pandemic	14
Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization	14
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy	14

Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover	14
Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial	14
Non-response did not affect prevalence estimates of asthma and respiratory symptoms - results from a postal questionnaire survey of the general population	13
Asthma in COVID-19 patients: An extra chain fitting around the neck?	13
Differences in disease presentation between men and women with sarcoidosis: A cohort study	13
German Respiratory Society guidelines for diagnosis and treatment of adults suffering from acute, subacute and chronic cough	13
Predictive value of chest CT scoring in COVID-19 patients in Wuhan, China: A retrospective cohort study	13
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry	13
Reduced pulmonary function, low-grade inflammation and increased risk of total and cardiovascular mortality in a general adult population: Prospective results from the Moli-sani study	13
Clusters of comorbidities in idiopathic pulmonary fibrosis	13
The influence of smoking on asthma in the real-life	13
Multidimensional indices in the assessment of chronic obstructive pulmonary disease	13
Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosis	13
The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease	13
Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis	13
Suggestions for lung function testing in the context of COVID-19	13
Outcomes of SARS-CoV-2 infection in patients with pulmonary sarcoidosis: A multicenter retrospective research network study	13
Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index	13
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma	12
Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation	12
Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany	12
Urinary volatile organic compound metabolites and reduced lung function in U.S. adults	12
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits	12
The S100 calcium-binding protein A4 level is elevated in the lungs of patients with idiopathic pulmonary fibrosis	12
Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease	12
Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 cases	12
Lung imaging in bronchopulmonary dysplasia: a systematic review	12
Non-invasive ventilation improves exercise tolerance and peripheral vascular function after high-intensity exercise in COPD-HF patients	12
Bronchiectasis and inhaled tobramycin: A literature review	12
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial	12
Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in Austria	11
Outcomes and prognostic factors of decompensated pulmonary hypertension in the intensive care unit	11
Clinical, radiological, and pathological evaluation of “NSIP with OP overlap” pattern compared with NSIP in patients with idiopathic interstitial pneumonias	11
Exclusive ambulatory management of spontaneous pneumothorax with pigtail catheters, a prospective multicentric study	11
In-line treatments and clinical initiatives to fight against COVID-19 outbreak	11
Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity	11
The role of lung macrophages in chronic obstructive pulmonary disease	11
Pneumothorax and barotrauma in invasively ventilated patients with COVID-19	11
Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients’ data using machine learning - Based on the ARCTIC study	11
Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial	11
Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment	11
Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis	11
Long COVID outcomes in an asthmatic cohort and its implications for asthma control	11
Risk of incident dementia and cognitive impairment in patients with chronic obstructive pulmonary disease (COPD): A large UK population-based study	11
Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation	11
Covid-19 and in situ pulmonary artery thrombosis	11
Patient characteristics associated with adherence to pulmonary nodule guidelines	11
HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis	11
Cardiopulmonary exercise testing in patients with asthma: What is its clinical value?	11
Association of obesity-related inflammatory pathways with lung function and exercise capacity	11
COPD exacerbation phenotypes in a real-world five year hospitalisation cohort	11
BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization	11
Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort	11
A patient decision aid for mild asthma: Navigating a new asthma treatment paradigm	11
Assessing the need for transfer to the intensive care unit for Coronavirus-19 disease: Epidemiology and risk factors	10
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?	10
SARS-CoV-2 infection in alpha1-antitrypsin deficiency	10
Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension	10
Clinical and radiological characteristics of ultrasonic humidifier lung and summer-type hypersensitivity pneumonitis	10
Pneumocystis pneumonia after lung transplantation: A retrospective multicenter study	10
High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis	10
sIL-2R levels predict the spontaneous remission in sarcoidosis	10
Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry	10
Clinical outcomes in Mycobacterium xenopi versus Mycobacterium avium complex pulmonary disease: A retrospective matched cohort study	10
Patients' and physicians’ perspectives on the burden and management of asthma: Results from the APPaRENT 2 study	10
Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthma	10
Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature	10
The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control	10
Immediate physiological effects of acute electronic cigarette use in humans: A systematic review and meta-analysis	10
High fitness levels offset the increased risk of chronic obstructive pulmonary disease due to low socioeconomic status: A cohort study	10
Respiratory symptoms and mortality in four general population cohorts over 45 years	10
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)	10
Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis	9
Frequency and characterization of CTEPH and CTEPD according to the mPAP threshold > 20 mm Hg: Retrospective analysis from data of a prospective PE aftercare program	9
The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension	9
Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease	9
Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China	9
Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population	9
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety	9
SMART for the treatment of asthma: A network meta-analysis of real-world evidence	9
Association of low FVC spirometric pattern with WTC occupational exposures	9
Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease	9
Updated prevalence, predictors and treatment outcomes for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation	9
Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers	9
Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany	9
Macklin effect on baseline chest CT scan accurately predicts barotrauma in COVID-19 patients	9
Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success	9
Corticosteroid refractory sarcoidosis	9
Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation	9
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma	9
The association between carotid-femoral pulse-wave velocity and lung function in the Swedish CArdioPulmonary bioImage study (SCAPIS) cohort	9
Interactions between microbiome and underlying mechanisms in asthma	9
Predictive factors for success of awake proning in hypoxemic respiratory failure secondary to COVID-19: A retrospective cohort study	9
Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study	8
A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease	8